Home › Cervical Cancer › NCT00900575

Cervical Cancer Detection Using Optical Spectroscopy

Who can join

Ages 18 and older · Women · Healthy volunteers welcome

Inclusion Criteria:

* undergoing colposcopy for the diagnosis of cervical cancer
* LEEP for the treatment of cervical cancer in early stages.
* Follow-up Pap smear in surveillance

Exclusion Criteria:

* Women under the age of 18 (minors) will be excluded from this study.
* patients will be excluded if she has had a recent episode of bleeding or preterm labor.
* Subjects who are not competent to give consent will excluded

About the study

The objective of the work described in this protocol is to determine the optical signatures of cervical dysplasia using optical technologies.

What is being tested

• Optical Spectroscopy Bench-Top System (device)
• Portable Optical Spectrometer (device)
• Transvaginal colposcope (device)

Sponsor: Duke University · Participants: 350 · Started: 2006-05

Contact the study team

• Nimmi Ramanujam, Ph.D. · Phone: 919-660-5307

Official record on ClinicalTrials.gov — NCT00900575

Locations in the U.S.

Conditions

• Cervical Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.